Infectious Diseases (except HIV/AIDS)
Showing page 237 of 716 pages of list content
-
SARS-CoV-2 spike T cell responses induced upon vaccination or infection remain robust against Omicron
This article's authors -
NATIONAL SCALE REAL-TIME SURVEILLANCE OF SARS-COV-2 VARIANTS DYNAMICS BY WASTEWATER MONITORING IN ISRAEL
This article's authors -
Reliably Assessing Duration of Protection for COVID-19 Vaccines
This article's authors -
Effectiveness of CoronaVac, ChAdOx1, BNT162b2 and Ad26.COV2.S among individuals with prior SARS-CoV-2 infection in Brazil
This article's authors -
BNT162b2 boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19
This article's authors -
Can individuals with suboptimal antibody responses to conventional antiviral vaccines acquire adequate antibodies from SARS-CoV-2 mRNA vaccination?
This article's authors -
SARS-CoV-2 seroprevalence in Kaduna State, Nigeria during October/November 2021, following three waves of infection and immediately prior to detection of the Omicron variant
This article's authors -
Risk of Myopericarditis following COVID-19 mRNA vaccination in a Large Integrated Health System: A Comparison of Completeness and Timeliness of Two Methods
This article's authors -
Transmission of SARS-CoV-2 among children and staff in German daycare centers: results from the COALA study
This article's authors -
A novel assessment method for COVID-19 humoral immunity duration using serial measurements in naturally infected and vaccinated subjects
This article's authors